Published in Clin Ophthalmol on July 30, 2010
Ultra-widefield retinal MHz-OCT imaging with up to 100 degrees viewing angle. Biomed Opt Express (2015) 0.99
Wide-field fundus autofluorescence corresponds to visual fields in chorioretinitis patients. Clin Ophthalmol (2011) 0.97
Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect (2013) 0.95
Role of wide-field autofluorescence imaging and scanning laser ophthalmoscopy in differentiation of choroidal pigmented lesions. Int J Ophthalmol (2014) 0.84
Update on wide- and ultra-widefield retinal imaging. Indian J Ophthalmol (2015) 0.76
A prospective, observational study on the application of ultra-wide-field angiography in the evaluation and management of patients with anterior uveitis. PLoS One (2015) 0.76
A pilot study to compartmentalize small melanocytic choroidal tumors and choroidal vessels with speckle-noise free 1050 nm swept source optical coherence tomography (OCT choroidal "tumoropsy"). Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Ultra-widefield fundus imaging in gas-filled eyes after vitrectomy. BMC Ophthalmol (2017) 0.75
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology (2000) 3.94
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol (1966) 2.34
Standardized echography: basic principles, clinical applications, and results. Int Ophthalmol Clin (1979) 2.01
Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture. Am J Ophthalmol (1977) 1.60
Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol (1973) 1.47
The Collaborative Ocular Melanoma Study: an overview. Cancer Control (2004) 1.37
Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol (2000) 1.33
Pathological and prognostic features of uveal melanomas. Can J Ophthalmol (2004) 1.31
Histogenesis of malignant melanomas of the uvea. II. Relationship of uveal nevi to malignant melanomas. Cancer (1967) 1.21
Natural history of indeterminate pigmented choroidal tumors. Ophthalmology (1994) 1.15
Clinical features of small choroidal melanoma. Curr Opin Ophthalmol (2002) 1.10
Correlations of the neuroretinal rim area with ocular and general parameters in normal eyes. Ophthalmic Res (1988) 1.08
Malignant melanoma of the choroid and ciliary body. A differential diagnosis in clinical echography. Bibl Ophthalmol (1975) 1.03
A clinical study of choroidal nevi. AMA Arch Ophthalmol (1959) 1.01
Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope. Br J Ophthalmol (1995) 1.01
Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology (1986) 0.93
Clinical factors in the identification of small choroidal melanoma. Can J Ophthalmol (2004) 0.93
Risk factors for growth and metastasis of small choroidal melanocytic lesions. Trans Am Ophthalmol Soc (1995) 0.91
Images in cardiovascular medicine. Wide-field scanning laser ophthalmoscope imaging and angiography of central retinal vein occlusion. Circulation (2010) 0.89
Melanoma arising de novo over a 16-month period. Arch Ophthalmol (1988) 0.86
Standardized a-scan echographic diagnosis of choroidal malignant melanomas. Arch Ophthalmol (1977) 0.86
Digital imaging in differential diagnosis of small choroidal melanoma. Graefes Arch Clin Exp Ophthalmol (2006) 0.85
Epidemikological investigation of increased incidence of choroidal melanoma in a single population of chemical workers. Int Ophthalmol Clin (1980) 0.82
Malignant melanoma of the choroid as related to coexistent benign nevus. Acta Ophthalmol (Copenh) (1975) 0.82
Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas. Invest Ophthalmol Vis Sci (2008) 0.80
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina (2006) 3.09
Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol (2002) 2.95
Diabetic retinopathy: Early diagnosis and effective treatment. Dtsch Arztebl Int (2010) 2.33
Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology (2010) 2.21
Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg (2013) 2.12
Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology (2009) 1.90
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2009) 1.83
The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol (2003) 1.74
Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases. Am J Ophthalmol (2006) 1.66
Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol (2010) 1.57
Long-term functional outcome of macular hole surgery correlated to optical coherence tomography measurements. Clin Experiment Ophthalmol (2007) 1.56
Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol (2009) 1.52
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci (2003) 1.50
Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure. Acta Ophthalmol Scand (2007) 1.49
Real-time intraocular pressure measurement in standard and microcoaxial phacoemulsification. J Cataract Refract Surg (2010) 1.48
Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol (2002) 1.45
Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol (2007) 1.45
Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol (2003) 1.42
Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci (2004) 1.41
Multi-MHz retinal OCT. Biomed Opt Express (2013) 1.36
Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol (2003) 1.33
Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest Ophthalmol Vis Sci (2002) 1.30
Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina (2007) 1.28
Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol (2005) 1.15
In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
Evaluation of a novel Scheimpflug-based non-contact tonometer in healthy subjects and patients with ocular hypertension and glaucoma. Br J Ophthalmol (2013) 1.13
The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci (2008) 1.12
Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol (2003) 1.11
Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens. Retina (2013) 1.11
Residual cellular proliferation on the internal limiting membrane in macular pucker surgery. Retina (2012) 1.10
Indications and clinical outcome of capsular tension ring (CTR) implantation: A review of 9528 cataract surgeries. Clin Ophthalmol (2007) 1.06
Central serous chorioretinopathy. Ophthalmologica (2014) 1.05
Five-year follow-up of macular hole surgery with peeling of the internal limiting membrane: update of a prospective study. Retina (2006) 1.05
Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol (2010) 1.05
Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Invest Ophthalmol Vis Sci (2008) 1.05
A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol (2007) 1.04
Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care (2012) 1.04
Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci (2003) 1.04
Vital dyes for macular surgery: a comparative electron microscopy study of the internal limiting membrane. Retina (2009) 1.03
Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol (2006) 1.03
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol (2013) 1.02
Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Clin Ophthalmol (2012) 1.01
In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg (2008) 1.01
Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes. Invest Ophthalmol Vis Sci (2011) 1.01
Transpupillary thermotherapy (TTT) in circumscribed choroidal hemangioma. Graefes Arch Clin Exp Ophthalmol (2001) 1.01
Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research. Graefes Arch Clin Exp Ophthalmol (2014) 1.01
Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in Germany: Model analysis from the perspective of Germany's statutory health insurance system. Clin Ther (2010) 1.01
Peripheral fundus autofluorescence is increased in age-related macular degeneration. Invest Ophthalmol Vis Sci (2012) 1.01
Epiretinal membrane characteristics correlate with photoreceptor layer defects in lamellar macular holes and macular pseudoholes. Retina (2015) 1.00
Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci (2006) 1.00
Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci (2003) 0.99
In vivo confocal microscopy of filtering blebs after trabeculectomy. Arch Ophthalmol (2006) 0.99
Focal and panretinal photocoagulation with a navigated laser (NAVILAS®). Acta Ophthalmol (2010) 0.98
Toxicity of indocyanine green in vitreoretinal surgery. Dev Ophthalmol (2008) 0.98
Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica (2012) 0.97
Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Invest Ophthalmol Vis Sci (2009) 0.97
Wide-field fundus autofluorescence corresponds to visual fields in chorioretinitis patients. Clin Ophthalmol (2011) 0.97
The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment. Invest Ophthalmol Vis Sci (2007) 0.96
The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol (2009) 0.95
Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis. Curr Eye Res (2013) 0.95
Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Retina (2014) 0.95
Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Exp Eye Res (2008) 0.95
Filtering blue light reduces light-induced oxidative stress, senescence and accumulation of extracellular matrix proteins in human retinal pigment epithelium cells. Clin Experiment Ophthalmol (2011) 0.95
Morphological and immunohistochemical changes after corneal cross-linking. Cornea (2013) 0.95
Visual loss as a first sign of adult-type chronic myeloid leukemia in a child. Am J Ophthalmol (2005) 0.95
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina (2015) 0.95